timestamp,ticker,BUY/SELL,Signal,AI score,Sent,RSI,Vlty,F-Score,Conf,is_healthy,price,status,AI
2026-02-26T11:47:13.478980-05:00,PLTR,BUY,Signal: STAR_PROACTIVE_STAR_ENTRY,AI: 85,0.55,,0.2353,8,85,True,134.74,FILLED,"Strong fundamental positive with Palantir Foundry explicitly powering OneMedNet's platform, indicating significant business adoption and accelerated recurring revenue in the AI/life sciences sector. This direct positive catalyst is further supported by a broader positive outlook for the software sector, with Raymond James noting a potential tradeable bounce and signs of selling exhaustion. Technical indicators (RSI 50.0, SMA-20 Stretch 0%) are perfectly neutral, suggesting the stock is not overbought or oversold, providing a balanced technical backdrop. Analyst consensus, institutional flow, and insider momentum are also neutral, while the overall market context shows slight headwinds (QQQ Bearish, SPY/QQQ down today) but with normal VIX conditions, which do not negate the strong company-specific and sector tailwinds."
2026-02-26T11:43:09.826919-05:00,PLTR,BUY,Signal: STAR_PROACTIVE_STAR_ENTRY,AI: 85,0.55,40.77,0.2283,8,85,True,135.14,FILLED,"PLTR benefits from a direct positive catalyst as OneMedNet expands its platform 'powered by Palantir Foundry,' indicating continued product adoption and growth. This is reinforced by positive sector-specific news from Raymond James and other sources suggesting a tradeable bounce and exhaustion of selling in software stocks. While analyst consensus, institutional flow, and insider momentum are neutral, and the broader QQQ trend is bearish, the specific positive business development and robust sector sentiment provide a strong tailwind. Technicals (RSI 40.77, SMA-20 stretch -1.91%) are neutral, not indicating an overbought condition and providing room for upside."
2026-02-26T11:43:08.523908-05:00,MSFT,SELL,Signal: EXIT_SELL_PARTIAL_25,AI: 60,-0.20,,0.1277,5,60,True,400.03,FILLED,"Broader tech market weakness, indicated by Nasdaq's 1.9% drop and a Bearish QQQ trend, creates a negative environment. This is partially offset by a notable 14.3% insider buy-side activity over 14 trades, suggesting internal confidence. Stock-specific technicals (RSI 50.0, 0% SMA-20 stretch), analyst consensus, and institutional flow are all neutral, indicating no immediate internal catalysts or risks."
2026-02-26T10:25:16.732568-05:00,AVGO,BUY,Signal: BUY,AI: 30,0.61,38.32,0.1244,8,30,True,309.88,FILLED_CONFIRMED,"Strong conviction for a buy, primarily driven by highly positive news regarding Broadcom's new AI chip shipments to Fujitsu and plans for wider rollout, coupled with confirmed stronger fundamentals post-panic. This is significantly reinforced by the 1.0% insider buy-side activity across 97 trades. Technical indicators, with an RSI of 38.3 and the stock trading -5.9% below its SMA-20, suggest a recent pullback, presenting a potentially attractive entry point. Analyst consensus and institutional flow remain neutral, which is the only tempering factor."
2026-02-25T14:59:27.135073-05:00,CEG,SELL,Signal: STAR_EXIT_SELL_PARTIAL_50,AI: 85,-0.12,63.73,0.2315,7,85,True,326.90,FILLED_CONFIRMED,"CEG is down 17% year-to-date with retail investor sentiment cooling significantly from bullish to neutral caution. While the RSI at 63.7 shows some momentum, the stock is overextended with a 15.7% stretch from its 20-day SMA, indicating potential for a pullback. Mizuho recently lowered its price target to $330, and there's no insider buying, reinforcing a cautious outlook despite positive future power price projections for 2025."
2026-02-25T13:37:12.853245-05:00,LLY,BUY,Signal: STAR_PROACTIVE_STAR_ENTRY,AI: 90,0.50,,0.0876,8,90,True,1033.87,FILLED_CONFIRMED,"LLY presents a strong positive fundamental narrative with successful Phase 3 trials (VIVID-2) and demonstrated resilience in the GLP-1 market against competitor price cuts. The analyst consensus, while 'Neutral', includes a high target of $1350, suggesting significant upside potential. Technical indicators (RSI 50.0, SMA-20 0%), institutional flow, and insider momentum are all neutral, indicating that while fundamental news is very strong, a clear immediate catalyst for accelerated movement is absent from market sentiment or technicals. The broader bearish QQQ trend introduces a minor cautious note, but the company-specific positive news and long-term growth outlook are compelling."
2026-02-25T12:43:12.178952-05:00,ASML,BUY,Signal: MOMENTUM_BREAKOUT,AI: 90,0.50,,0.1201,8,90,True,1532.19,FILLED_CONFIRMED,"ASML's explicit identification of AI as the main long-term growth driver, a significant shift from previous reports, provides strong fundamental tailwinds. This is reinforced by its inclusion in Goldman Sachs' list of outperforming capital-intensive companies, suggesting resilience during market shifts. Despite neutral technicals (RSI 50.0, SMA-20 stretch 0%), neutral analyst consensus, and a bearish QQQ trend, the strong positive fundamental narrative change suggests upside potential, aligning with the hard-learned lesson to prioritize robust long-term demand and fundamental strength over mixed or neutral short-term sentiment."
2026-02-25T12:39:08.190201-05:00,ASML,BUY,Signal: MOMENTUM_BREAKOUT,AI: 90,0.50,,0.1191,8,90,True,1530.31,FILLED_CONFIRMED,"ASML's updated 2025 annual report explicitly identifies AI demand as the main long-term growth driver, a significant shift in company outlook from 2024, indicating strong fundamental tailwinds. Additionally, ASML is included in Goldman Sachs' outperforming 'capital-intensive' basket, suggesting resilience and investor preference in the current market. Technicals (RSI 50.0, SMA-20 Stretch 0%), analyst consensus (Neutral), and institutional flow are all neutral. Despite a bearish QQQ trend, the strong, positive company-specific fundamental news provides a high-conviction buy signal."
